ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting the Accomplices of MYC in MYC-driven Medulloblastoma||Sanford-Burnham Medical Research Institute / Robert Wechsler-Reya, Ph.D.||Innovation Grants||2014||California|
|Mechanisms and Targeted Inhibition of NT5C2 Mutations in Relapsed ALL||Columbia University / Adolfo A. Ferrando, M.D., Ph.D.||Innovation Grants||2014||New York|
|Modeling Juvenile Myelomonocytic Leukemia with Patient-Derived Induced Pluripotent Stem Cells||Children's Hospital of Philadelphia / Mitchell Weiss, M.D., Ph.D.||Innovation Grants||2014||Pennsylvania|
|Targeting the Six1/Eya Transcriptional Complex to Inhibit Pediatric Sarcomas||University of Colorado Denver / Heide Ford, Ph.D.||Innovation Grants||2014||Colorado|
|Targeting eEF2 Kinase in Neuroblastoma||University of California San Francisco / William Weiss, M.D., Ph.D.||Innovation Grants||2014||California|
|Converting the Glioblastoma Multiforme Tumor-Associated Macrophage Phenotype||The Johns Hopkins University School of Medicine / Alan D. Friedman, M.D.||Innovation Grants||2014||Maryland|
|Targeting MYC/MYCN-driven Transcriptional Amplification in Pediatric Cancer||Dana-Farber Cancer Institute / Rani George, M.D., Ph.D.||Innovation Grants||2014||Massachusetts|
|Development of AAV Vectors for Efficient Targeting and Elimination of Osteosarcoma Tumor-Initiating Cells||University of Florida / Steven Ghivizzani, Ph.D.||Innovation Grants||2014||Florida|
|Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer||Baylor College of Medicine / Stephen Gottschalk, M.D.||Innovation Grants||2014||Texas|
|Developing Personalized (precision) Medicine Strategies to Optimize Pediatric Brain Tumor Management||Washington University / David Gutmann, M.D., Ph.D.||Innovation Grants||2014||Missouri|